Roche | Dr Thomas Schinecker Dr Thomas Schinecker Chief Executive Officer Roche Group (Member of the CEC since 2019)
Thomas Schinecker - Wikipedia Thomas Schinecker Thomas Schinecker (born April 23, 1975 in Simbach am Inn) is an Austrian-German pharmaceutical executive and the chief executive officer of the Roche Group since March 2023 He succeeded Severin Schwan, who was elected chairman of the board of directors of the Roche Group [2][3][4]
Thomas Schinecker - CEO Roche Group - LinkedIn Since March 2023, I’ve had the honour of serving as CEO of the Roche Group Together with my colleagues, we will tackle challenges with courage, passion and integrity
Matt Sause appointed global CEO of Roche Diagnostics Roche announced that Matt Sause, currently Head of Roche Diagnostics’ North America Region, will become CEO of Roche Diagnostics and a member of the Corporate Executive Committee effective January 1, 2023
Roche CEO: Future of cancer treatment, AI in medicine and trial . . . In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s largest health care companies Nicolai and Thomas discuss Roche’s leadership in cancer treatment, breakthroughs in diagnostics, and the impact of cutting-edge R D in areas like precision medicine and AI
Roche | Meet our leadership team Executive CommitteeAbout Roche The Executive Committee's composition and the curricula vitae of its members
Roche’s New CEO Thomas Schinecker - PharmaBoardroom In July, Roche announced that after 14 years Severin Schwan would be stepping into a board chair role and passing the CEO baton to Thomas Schinecker Austrian-born Schinecker gained considerable notoriety as the CEO of Roche Diagnostics where he headed up COVID-19 test kit development and grew sales by 29 percent to USD 19 4 billion, but his